GL1X · GenesisL1 explorer

Research workbench

Structure of imp-13 metallo-beta-lactamase complexed with hydrolysed imipenem

Analyse Structure of imp-13 metallo-beta-lactamase complexed with hydrolysed imipenem in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6RZR
Type
protein
Length
436 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q7WYA8
Ligands
8YF, ZN
Pockets
6 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 28% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein21928% helix, 31% strandQ7WYA8
BBeta-lactamase (EC 3.5.2.6)protein21727% helix, 31% strandQ7WYA8

Ligands and binding sites

  • 8YF · (2R)-2-[(2S,3R)-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-4-(2-methanimidamidoethylsulfanyl)-2,3-dihydro-1H-pyrrole-5-carboxylic acid · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 12 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14030.710.8244EDO, ZN, 8YF
21410.480.7823ZN, 8YF
31010.400.7716EDO
4540.360.7913empty
5510.280.7511empty

Interfaces

1 interface between chains.

  • A–B · 783 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 6RZR · Structure of IMP-13 metallo-beta-lactamase complexed with hydrolysed imipenem · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.